Issue 27: The Complexities Of Early Phase Ophthalmic Drug Development
Source: Altasciences
Drug development in the ocular space has specific challenges. In exploring how an end-to-end solution can facilitate a path to Phase 2, the speaker breakdowns the entire pathway solution.
Several topics discussed, among others, include:
- Prototype Development, Formulation, and Manufacturing
- CDMO Case Study
- Preclinical Research
- Preclinical Caser Study: Safety Assessment of Intravitreal Implants
access the Podcast!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Altasciences
This website uses cookies to ensure you get the best experience on our website. Learn more